Focusing on the forthcoming changes brought about by the NHS White Paper and NICE Assessments of Medical Technologies and Diagnostics.
Why You Should Attend:
The NHS is implementing structural reforms that are unprecedented in magnitude since it was founded in 1948. In addition, the National Institute of Health & Clinical Excellence (NICE) is the first national organisation in the world to commence systematically assessing medical technologies and diagnostics to determine their relative value and whether wider NHS use is warranted.
These changes will have a significant impact on Industry’s business with the NHS and may have international market ramifications. Industry’s success depends on how well it adapts and aligns its business strategy to the new market conditions.
This conference will explain the forthcoming changes and answer what it means for your business and how to adapt for excelling in these new conditions.
The Presenters & Format:
Senior NHS and Health Economic experts who are at the cutting edge of the changes currently taking place will provide attendees with a detailed understanding of the key issues of importance to Industry’s future success.
Plenary presentations along with discussion and two separate workshop sessions will provide attendees with ample opportunity to consider, challenge and learn how the NHS and NICE changes will impact upon their own business and develop potential strategies for succeeding in the new landscape.
Objectives of the Day:
This event aims to focus on the key issues influencing Industry’s future business with the NHS and provide the attendee with insights into how commercial business can thrive in the new landscape.
‘Opening Doors to the NHS’ aims to improve the interface between Industry and the NHS for the mutual success of both parties.